View in EDS HTML Full Text PDF Full Text

Multicenter study of universal prophylaxis versus pre‐emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation.

Saved in:
Bibliographic Details
Title: Multicenter study of universal prophylaxis versus pre‐emptive therapy for patients at intermediate risk (R+) for CMV following heart transplantation.
Authors: Lerman, Joseph B.1,2 (AUTHOR) Joseph.Lerman@Duke.edu, Green, Cynthia L.2,3 (AUTHOR), Molina, Maria R.4 (AUTHOR), Maharaj, Valmiki5 (AUTHOR), Ortega‐Legaspi, Juan M.4 (AUTHOR), Sen, Sounok6 (AUTHOR), Flattery, Maureen7 (AUTHOR), Maziarz, Eileen K.8 (AUTHOR), Shah, Keyur B.7 (AUTHOR), Martin, Cindy M.9 (AUTHOR), Alexy, Tamas5 (AUTHOR), Shah, Palak10 (AUTHOR), Morris, Alanna A.11 (AUTHOR), DeVore, Adam D.1,2 (AUTHOR), Cole, Robert T.12 (AUTHOR)
Source: Clinical Transplantation. Oct2023, Vol. 37 Issue 10, p1-9. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09020063
DOI:10.1111/ctr.15065